Followers | 507 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, July 01, 2015 11:31:24 AM
bullish
bull flag
## source: finance.yahoo.com
Thu, 11 Jun 2015 13:20:27 GMT ~ ORAGENICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/150611/ogen8-k.html
*********************************************************
Wed, 10 Jun 2015 13:12:01 GMT ~ Intrexon and Oragenics Expand Collaboration to Pursue Development of Biotherapeutics for the Oral Cavity
[at noodls] - Companies to Progress ActoBiotic™ AG013 for Treatment of Oral Mucositis Oragenics Now A Clinical Stage Company June 10, 2015 08:15 AM Eastern Daylight Time GERMANTOWN, Md. & TAMPA, Fla.--(BUSINESS WIRE)--Intrexon ...
read full: http://www.noodls.com/view/8691E282FE76FAE0BCDDE94C9BF1163A96574906
*********************************************************
Wed, 10 Jun 2015 12:32:02 GMT ~ June 10, 2015 - Intrexon and Oragenics Expand Collaboration to Pursue Development of Biotherapeutics for the Oral Cavity
[at noodls] - Intrexon and Oragenics Expand Collaboration to Pursue Development of Biotherapeutics for the Oral Cavity Companies to Progress ActoBiotic™ AG013 for Treatment of Oral Mucositis Oragenics Now A Clinical ...
read full: http://www.noodls.com/view/8D964A0EDD1CBD5ACC59EC6057EE1D329A096CF6
*********************************************************
Wed, 10 Jun 2015 12:15:00 GMT ~ Intrexon and Oragenics Expand Collaboration to Pursue Development of Biotherapeutics for the Oral Cavity
[Business Wire] - Intrexon Corporation , a leader in synthetic biology, and Oragenics , today announced a new Exclusive Channel Collaboration to pursue development of biotherapeutics for oral mucositis and other diseases and conditions of the oral cavity, throat, and esophagus, including clinical advancement of the ActoBiotic™ AG013 for the treatment of OM.
read full: http://finance.yahoo.com/news/intrexon-oragenics-expand-collaboration-pursue-121500790.html
*********************************************************
Wed, 20 May 2015 17:04:30 GMT ~ ORAGENICS INC Financials
read full: http://finance.yahoo.com/q/is?s=ogen
*********************************************************
$OGEN charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$OGEN company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/OGEN/company-info
Ticker: $OGEN
OTC Market Place: Not Available
CIK code: 0001174940
Company name: Oragenics, Inc.
Company website: http://www.oragenics.com
Incorporated In: FL, USA
Business Description:
$OGEN share structure
## source: otcmarkets.com
Market Value: $49,839,153 a/o Jun 30, 2015
Shares Outstanding: 36,378,944 a/o May 08, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$OGEN extra dd links
Company name: Oragenics, Inc.
Company website: http://www.oragenics.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=OGEN+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=OGEN+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=OGEN+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/OGEN/news - http://finance.yahoo.com/q/h?s=OGEN+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/OGEN/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/OGEN/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=OGEN+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/OGEN
DTCC (dtcc.com): http://search2.dtcc.com/?q=Oragenics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Oragenics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Oragenics%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.oragenics.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.oragenics.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.oragenics.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/OGEN
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001174940&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/OGEN/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/OGEN/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=OGEN&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=OGEN
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/OGEN/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=OGEN+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=OGEN+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=OGEN
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=OGEN
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=OGEN+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/OGEN/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=OGEN+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/OGEN.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=OGEN
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/OGEN/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/OGEN/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/OGEN
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/OGEN
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/OGEN:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=OGEN
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=OGEN
$OGEN DD Notes ~ http://www.ddnotesmaker.com/OGEN
Recent OGEN News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 01:27:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 12:00:17 PM
- Oragenics Appoints William “Frank” Peacock MD as Chief Clinical Officer • GlobeNewswire Inc. • 05/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 12:00:41 PM
- Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine • GlobeNewswire Inc. • 05/17/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 12:00:22 PM
- Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial • GlobeNewswire Inc. • 05/16/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 05:00:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 12:14:33 PM
- Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia • GlobeNewswire Inc. • 05/07/2024 12:00:00 PM
- Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards • Business Wire • 04/19/2024 09:50:00 PM
- Oragenics, Inc. Files 10K and Provides Company Update • Business Wire • 04/01/2024 01:05:00 PM
- Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion • Business Wire • 03/18/2024 11:00:00 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/06/2024 09:24:29 PM
- Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion • Business Wire • 03/05/2024 12:45:00 PM
- Oragenics Announces Closing of Public Offering • Business Wire • 03/01/2024 09:04:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/29/2024 09:41:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 02:03:04 PM
- Oragenics Announces Pricing of Public Offering • Business Wire • 02/28/2024 02:25:00 AM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 02/27/2024 10:09:12 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/27/2024 10:04:34 PM
- Oragenics Announces Proposed Public Offering • Business Wire • 02/27/2024 09:33:00 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 02/13/2024 01:06:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:45:18 PM
- Oragenics, Inc. Announces Leadership Transition • Business Wire • 02/12/2024 09:41:00 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM